SATB2 and prostate carcinoma: We first compared the expression of SATB2 in human normal prostate epithelial cells (PrEC), prostate cancer cell lines (C4-2B, LNCaP, DU-145, and PC-3), and prostate CSCs using Western blot analysis and immunocytochemistry.